Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) recenltly announced Iclusig distribution agreement with an Australian company. The move is expected to expand the market for the drug so that better revenue can be realized. With the cost of the drug being fairly high, even a small group of patents on commercial supply of the drug is enough to uplift the financial status of the company. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock opened at $8.48 in last session, and closed at $8.99, while the day range of ARIA stock is $8.22-9.05.The stock showed a positive weekly performance of 2.98%.
Ballard Power Systems Inc. (USA) (NASDAQ:BLDP) declared their fourth quarter and full year 2013 results. The operating results were quite strong on the back of its improved execution strategy. Ballard Power Systems Inc. (USA) (NASDAQ:BLDP) stock opened at $3.25, in last session and closed at $3.58, by gained 6.87%.The 52 week range was $0.69-$3.75.Company’s market capitalization is $391.49 million.
BioScrip (NASDAQ:BIOS)‘s stock had its “neutral” rating restated by Zacks in a report released on Friday, Stock Ratings Network reports. They currently have a $8.75 price target on the stock. Zacks target price would indicate a potential upside of 0.69% from the company’s current price. BioScrip Inc (NASDAQ:BIOS) stock loosed -12.32% and finished the last session at $7.40.The EPS of the stock remained -0.61.Company’s market capitalization is $504.01 million.
Novavax, Inc. (NASDAQ:NVAX)’s shares jumped 4.34% to $6.01. The company announced that it will host a conference call and webcast to report its fourth quarter and year-end 2013 financial results on Monday, March 10, 2014, at 4:30 p.m. ET. Novavax, Inc. (NASDAQ:NVAX) stock opened the session at $6.17, and closed the session at $6.65.The 52 week range of the NVAX stock remained $1.68-$6.92 and the day range was $6.17-$6.92.
Leave a Reply